The relationship between allergic diseases and internalising and externalising behaviours in Spanish children: a cross-sectional study

Berzosa-Grande Pilara, b*, González-Fraile Eduardoa, Sánchez-López Rocíob, Soria-Oliver Maríac, Rueda-Esteban Santiagod

aDepartment of Health Sciences, International University of La Rioja, UNIR, Logroño, Spain;

bIntelecto Psychological Centre, Jerez de la Frontera, Spain;

cFaculty of Health Sciences. Public University of Navarra, Navarra, Spain

dSan Carlos Clinic Hospital, Madrid, Spain


Introduction and objectives: The relationship between allergic diseases and behavioural disorders is still unclear. The objective of this study is to describe and compare children’s behaviour (internalising and externalising) across a sample of children between 6 and 11-years-old with and without allergic diseases.

Materials and methods: A cross-sectional, observational case-control study that comprises a survey of 366 families (194 cases and 172 controls) including a Child Behaviour Checklist (CBCL) and a sociodemographic questionnaire with questions related to family, school education, health conditions, and allergy symptoms was administered.

Results: Children with a diagnosis of allergy showed higher scores in the overall CBCL score (standardised mean differences [SMD] = 0.47; CI: 0.26–0.68) and in the internalising and externalising factors (SMD = 0.52 and SMD = 0.36, respectively) than non-allergic children. Odds ratio analyses showed a higher risk (OR = 2.76; CI 95% [1.61 to 4.72]) of developing a behavioural difficulty in children diagnosed with allergies. Age and level of asthma appears as modulatory variables.

Conclusions: Children diagnosed with allergies at age 6 to 11 years show larger behavioural problems than non-allergic children, especially in internalising behaviours. These findings suggest the importance of attending to them and treating them in the early stages of the diagnosis to avoid future psychological disorders.

Key words: allergy, behaviour, internalising and externalising, child, parent

*Corresponding author: Pilar Berzosa-Grande, International University of La Rioja, C/ Gran Vía Rey Juan Carlos I, 41, 26002 Logroño, La Rioja, Spain. E-mail address:

Received 29 July 2020; Accepted 18 November 2020; Available online 1 July 2021

DOI: 10.15586/aei.v49i4.192

Copyright: Berzosa-Grande MP et al.
License: This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0).


The prevalence of allergic diseases has increased for more than 50 years worldwide, especially in industrialised countries1 and in children under the age of 18.24 This rise in the prevalence of allergies have a great impact on societies and generates large health-care costs.5,6 Families and children with allergic diseases are particularly affected and bear the greatest burden7 which is reflected in a reduction in their quality of life,8 an increased risk of psychological disorders,9 and numerous medical and non-medical comorbidities.10

Over the past few decades, evidence about the relationship between common allergies (related to environmental factors, foods or drugs), their main symptoms (such as asthma, allergic rhinitis (AR) or atopic dermatitis (AD)) and mental health problems in children and young adults has become stronger.1114 Asthma has been related with a higher risk of internalising disorders (such as anxiety and depression),15 externalising disorders (such as oppositional defiant or disruptive behaviour disorders)16,17 or poorer social and mental well-being.18 Different studies with children and pre-schoolers with AR have shown a relationship with internalising and sleep problem behaviours.1922 In addition, AD has been associated in different studies with several mental comorbidities such as attention deficit disorder, anxiety and depression.23 However, a recent meta-analysis of 35 studies on AD has found opposite results.24

On the other hand, the relation between allergic diseases and these internalising/externalising difficulties is not clear. Some psychological approaches have suggested that children could have psychological adjustment difficulties because of an allergy and its symptoms,25 or that these could be influenced by intra-familiar or socio-emotional factors related with the family context.2629 Others have explored the relationship with an underlying biological process related to the serotoninergic system.30,31

Despite this evidence, there is still a lack of studies assessing outcomes with well-validated instruments that compare a clinical allergic sample with a similar control sample of non-allergic children, or that assess the possible relationship between multiple comorbid allergies and problematic behaviours.19

The aim of this study is to assess the relationship between allergic diseases and behavioural problems (internalising and externalising). It was also studied the possible influence of intra-familiar conditions (such as level of stress inside the family, affective expressions, resilience and parental authority) into the origin of behavioural problems in allergic children. In addition, we aim to assess the relation between the severity of the allergy (mild or moderate asthma and the number of allergic comorbidities) with the degree of behavioural problems.


Hypothesis and design

The principal hypothesis of this study was that children (aged 6 to 11 years) with a diagnosis of allergic disease would show higher behavioural problems (internalising and externalising problems), assessed with the Child Behaviour Checklist (CBCL)32 than children without a diagnosis of allergic disease.

The secondary hypothesis was that children (aged 6 to 11 years) with a diagnosis of allergic disease would show higher scores in the eight syndrome subscales of the CBCL scale32 (anxious/depressed, withdrawn/depressed, somatic complaints, social problems, thought problems, attention problems, rule-breaking behaviour and aggressive behaviour) than children without a diagnosis of allergic disease.

Third hypothesis was that there is a positive relation between the severity of the allergy (assessed by the degree of asthma and the number of allergic comorbidities) and the level of behavioural problems.

This study design was carried out as a multicentre, case-control, cross-sectional study.


The study population included two groups. The first group (cases) consisted of families with a child diagnosed with an allergic disease. To be eligible to be included in this group, families had to have a child: (1) male or female (from 6 years to 11 years), (2) being treated in an external paediatric pneumology/allergology service, (3) with a clinician diagnose of mild or moderate environmental allergy (including pollen, mould, dust or pets), food allergy, medication allergy, allergic asthma, AR or AD, (4) allergy symptomatology must be stable and well-controlled by a clinician. Exclusion criteria included: (1) children with a severe clinical diagnosis of allergy, (2) comorbidity of another primary pathology, (3) direct family (parents or siblings) with a severe mental disorder (DSM-V criteria) and (4) being hospitalised. The sample of this group was recruited from the Clinical Hospital of San Carlos, located in Madrid (Spain). A clinician informed families individually about the study and its purposes and asked them about their interest in participating in the study.

The second group (controls) consisted of families with healthy children. To be included in this group, families had to have a child: male or female (from 6 years to 11 years). Exclusion criteria for this group included having a child: (1) with a clinical diagnosis of allergy, (2) comorbidity of another primary pathology, (3) direct family (parents or siblings) with a severe mental disorder (DSM-V criteria) and (4) being hospitalised. The full sample of this group was recruited from a state financed school in Madrid (Spain). In this case, the team had a previous meeting with the families to inform them about the study and its purposes. Forms (informed consent and survey) were mailed by post to their homes. Families interested in participating forwarded the documentation with the requested information.

Parents of both groups signed the written informed consent form before their inclusion in the study. Study approval was obtained in April 2019 from the Ethical and Scientific Research Committee of the San Carlos Clinic Hospital, Madrid (Spain) (Internal Code: 19/108-E).


Sociodemographic and emotional climate in the family

To collect sociodemographic information, the team developed an ad hoc questionnaire with questions related to age, sex, number of brothers and sisters of the child, and family structure (nuclear, separated, adoptive, etc...).

To detect the emotional circumstances of the family context, a brief ad hoc questionnaire where parents used a 3-Likert scale (low, medium or high) was used to rate their perceived level of stress inside the family, affective expressions, resilience to copy with problems and difficulties, and their authority or effectiveness in establishing rules at home (Supplementary material).

Allergy information

Allergy information about the participants in the case group was collected directly from the medical file by a clinician. It includes allergen (pollen, mould, dust, pets, food and medication), level of asthma (mild or moderate), AD, AR and food intolerance. Participants in the control group were also asked about all of these questions in order to ensure that they did not suffer from allergies or show allergy symptoms.

Behavioural outcome measure

To assess the behavioural problems, parents completed the CBCL.32 The CBCL can be applied to subjects aged from 4 to 16 years. It includes 113 statements recorded in a 0–3 Likert scale (0 = “false or rarely”; 2 = “true or very often”). The items are grouped in nine independent factors: anxious/depressed, withdrawn/depressed, somatic complaints, social problems, attention problems, rule-breaking behaviour, aggressive behaviour and other problems. The scale gives three summary scores related to internalising behaviour problems (formed by the sum of the factors of anxious/depressed, withdrawn/depressed and somatic complaints), externalising behavioural problems (sum of rule-breaking behaviour and aggressive behaviour) and a total score (obtained by the addition of all the factors). To interpret the scores, direct scores must be converted to a T scale where scores between 65 and 70 are considered a critical borderline clinical range. Higher scores mean higher levels of behavioural problems. We used the Spanish version of the CBCL for children between 6 and 18 years.33

Parents completed the parent rating scale of the CBCL and the ad hoc questionnaires.

Sample size calculation

Taking into account that the 10% of the general child population can show any disruptive behaviour34 and accepting an alpha risk of 0.05 and a beta risk of 0.2 in a two-sided test, 195 subjects are necessary in both groups to find a statistically significant difference in proportions, expected to be 0.1 in allergic group and 0.2 in the control group.

Statistical analysis

Sample description is reported by means and SDs for continuous variables, whereas frequencies and percentages describe categorical variables.

To contrast the main hypothesis of the study, we used simple means of comparisons (Student’s t-test or the Mann–Whitney U test). In addition, simple mean difference and standardised mean differences (SMD) with 95% confidence intervals (CI) are reported. SMD can be easily interpreted following the rule of thumb: scores from 0 to 0.2 indicate a small effect, values close to 0.5 suggest medium effect, and 0.8 or above can be interpreted as large effect.35 Odds ratios (OR) and 95% confidence ratios (CI) were determined. To calculate the OR, we separated the obtained CBCL scores using a T score of 65 as the cut-off point, marked by the original authors of the scale as “clinical range.” An OR of >1 can be interpreted as higher odds of the described event occurring given the particular exposure. In case of any statistically significant differences in sociodemographic or familiar variables between groups, secondary analysis will be performed by logistic regression, adjusting for covariates.

The association between the allergy severity (assessed by the degree of asthma and the number of allergic comorbidities) and the level of behavioural problems was examined using a Student’s t-test (degree of asthma has only two categories) and a Pearson correlation (one participant could have from one to four allergies). For these dose-relation analyses, we used the allergic sample.

An independent and blinded statistician performed analyses using SPSS V.21 (IBM SPSS Statistics for MAC, Version 24.0. Armonk, NY: IBM Corp.) and Jamovi 1.2 (The jamovi project) Jamovi (Version 1.2).


Sample description

A total of 456 families were assessed for eligibility out of which 23 (5.04%) did not meet the selection criteria and 67 refused to participate (14.69%). Finally, we recruited a total sample of 366 families (80.26%; 194 cases and 172 controls) from May 2019 to July 2019. Table 1 presents the main sample characteristics obtained with the questionnaire divided by groups.

Table 1 Sociodemographic description of the sample.

Variables Total (N=366) Allergic (n=194) Control (n=172) P value
Age, mean (SD) 8.68 (1.71) 9.01 (1.62) 8.31 (1.72) <.001
Female gender, n (%) 173 (47.3) 85 (43.8) 88 (51.2) .160
Allergy, n (%)        
Pollen 163 (84.02)  
Mold 27 (13.91)  
Dust 24 (12.37)  
Pets 63 (32.47)  
Food 38 (19.58)  
Medication 5 (2.57)  
Level of asthma, n (%)        
Mild 151 (77.83)  
Moderate 43 (22.16)  
Severe 0  
Atopic dermatitis, n (%) 123 (63.4) 123 (63.4) 0 <.001
Rhinitis, n (%) 171 (88.14) 171 (88.14) 0 <.001
Alimentary intolerance, n (%) 12 (3.27) 12 (6.18) 0 <.001
Family structure, n (%)        
Nuclear 251 (68.6) 130 (67) 122 (70.9) .091
Separated or divorced 54 (14.7) 28 (14.4) 26 (15.1)  
Stepfamily 26 (7.1) 16 (8.2) 10 (5.8)  
Adoptive 5 (1.4) 1 (0.5) 4 (2.3)  
Single parent 20 (5.5) 15 (7.7) 5 (2.9)  
Others 10 (2.7) 4 (2.1) 5 (2.9)  
Family perceived stress        
Low 220 (60.2) 111 (57.2) 109 (63.4) .668
Medium 123 (33.6) 71 (36.6) 52 (30.2)  
High 23 (6.2) 12 (6.2) 11 (6.4)  
Parents affective expression        
Low 19 (5.2) 11 (5.7) 8 (4.7) .804
Medium 25 (6.8) 12 (6.2) 13 (7.6)  
High 322 (88) 171 (88.1) 151 (87.8)  
Parents resilience        
Low 64 (17.5) 31 (16) 33 (19.2) .187
Medium 187 (51.1) 94 (48.5) 93 (54.1)  
High 115(31.4) 69 (35.6) 46 (26.7)  
Authority effectiveness        
Low 37 (9.9) 18 (9.3) 19 (10.5) .508
Medium 189 (51.8) 106 (54.6) 83 (48.5)  
High 140 (38.5) 70 (36.1) 70 (40.9)  

The total sample had a mean age of 8.68 years, while the allergic group showed a higher mean age than the control group. Overall, allergic children reported allergies to environmental elements (pollen, mould, dust or pets). Further, 38 children indicated food allergies and only five showed allergy to pharmacological compounds. All children in the allergic sample were diagnosed with asthma, and 123 had AD. The most frequent family structure was traditional or nuclear followed by separated or divorced parents. The family context emotional circumstances assessment indicated that the level of stress was predominately low, with a high degree of affective expressions, and medium degree of resilience and authority.

No significant differences were observed between allergic and control groups in relation to intra-familiar conditions.

Comparisons of behaviour (CBCL) by group (cases and controls)

Table 2 shows the scores on the CBCL scale. The overall sample obtained a mean total score of 26.71, indicating non-clinical behaviour. Allergic children showed higher scores, with a significant mean difference of 10.27 points above the control group (SMD = 0.47; CI 95% [0.26 to 0.68]). Internalising and externalising subscales reported similar differences between groups with medium effect sizes (SMD = 0.52; CI 95% [0.32 to 0.73] and SMD = 0.36; CI 95% [0.15 to 0.56] respectively).

Table 2 Comparisons of CBCL scores by groups.

Total (N = 366) Allergic (n = 194) Control (n = 172) P Value Mean difference SMD (95% CI) OR (95% CI)
CBCL Total, mean (SD) 26.71 (21.32) 31.28 (22.45) 21.55 (18.74) <0.001 −10.27 0.47 (0.26–0.68) 2.76 (1.61–4.72)
Anxious/Depressed 3.39 (3.52) 4.06 (3.88) 2.63 (2.9) <0.001 −1.55 0.41 (0.21–0.62) 2.83 (1.41–5.66)
Withdrawn/Depressed 1.63 (2.32) 2 (2.65) 1.21 (1.8) <0.001 −0.88 0.34 (0.14–0.55) 1.5 (0.84–2.67)
Somatic complaints 2.33 (2.7) 3.03 (2.98) 1.54 (2.07) <0.001 −1.49 0.57 (0.36–0.78) 1.51 (1.38–4.53)
Social problems 2.45 (2.7) 2.93 (2.89) 1.91 (2.35) <0.001 −1.08 0.38 (0.18–0.59) 3.31 (1.52–7.19)
Thought problems 2.07 (2.53) 2.57 (2.71) 1.5 (2.18) <0.001 −1.18 0.43 (0.22–0.64) 2.41 (1.19–4.89)
Attention problems 4.18 (3.71) 4.69 (3.78) 3.61 (3.55) 0.002 −1.18 0.29 (0.09–0.5) 1.44 (0.71–2.91)
Rule-breaking behaviour 1.63 (1.96) 1.74 (2.11) 1.5 (1.76) 0.221 −0.25 0.12 (−0.08–0.33) 1.89 (0.72–4.91)
Aggressive behaviour 5.02 (4.61) 5.92 (4.81) 4 (4.16) <0.001 −1.93 0.42 (0.22–0.63) 2.5 (1.17–5.36)
Others 3.97 (2.96) 4.29 (3.02) 3.61 (2.86) 0.025 −0.69 0.26 (0.06–0.47)
Internalising 7.36 (7.29) 9.10 (8.14) 5.39 (5.59) <0.001 −3.93 0.52 (0.32–0.73) 2.45 (1.54–3.89)
Externalising 6.65 (6.14) 7.67 (6.41) 5.50 (5.62) <0.001 −2.18 0.36 (0.15–0.56) 1.77 (1.03–3.04)

CBCL: Child Behaviour Check List; CI: Confidence Interval; SD: Standard Deviation; SMD: Standardised Mean Difference; OR: Odds Ratio.

The remaining factors, except “rule-breaking,” showed similar statistical results (p > 0.025) with medium effect sizes. The biggest differences were detected in the “somatic complaints” (SMD = 0.57) and “thought problems” (SMD = 0.43) subscales, while the smallest differences were in the “attention problems” (SMD = 0.29) and “others” (SMD = 0.26).

Logistic regressions adjusting for covariates (age and number of siblings) reported similar results (P values <0.01 for the total score, internalising and externalising subscales, and P values less than 0.05 for the remaining factors except for “rule-breaking”). A comparison between the younger participants (6–8 years) and the older participants (9–11 years) showed smaller differences (SMD) in all scores, especially in externalising subdomain (Table 3).

Table 3 Comparisons of CBCL scores by groups and by age (under and over 9 years old).

Under 9 years Over 9 years
Allergic (n = 78) Control (n = 95) P Value SMD (95% CI) Allergic (n = 116) Control (n = 77) P Value SMD (95% CI)
CBCL Total, mean (SD) 30.69 (21.53) 19.08 (16.06) <0.001 0.62 (5.96–17.25) 31.68 (23.14) 24.61 (21.31) 0.033 0.31 (0.56–13.57)
Anxious/Depressed 4.01 (3.88) 2.28 (2.63) <0.001 0.53 (0.74–2.71) 4.10 (3.90) 3.08 (3.17) 0.056 0.28 (−0.02–2.07)
Withdrawn/Depressed 1.62 (1.96) 1.12 (1.81) 0.084 0.26 (−0.06–1.06) 2.27 (3.01) 1.34 (1.80) 0.016 0.35 (0.17–1.62)
Somatic complaints 3.05 (3.37) 1.38 (1.83) <0.001 0.63 (0.87–2.46) 3.02 (2.71) 1.74 (2.34) <0.001 0.49 (0.53–2.02)
Social problems 2.74 (2.66) 1.72 (1.95) 0.004 0.44 (0.52–2.67) 3.06 (3.05) 2.17 (2.77) 0.041 0.30 (0.03–1.74)
Thought problems 2.62 (82.63) 1.39 (2.13) <0.001 0.51 (0.5–1.94) 2.55 (2.79) 1.65 (2.26) 0.019 0.34 (0.15–1.65)
Attention problems 4.81 (3.86) 3.21 (3.30) 0.004 0.44 (0.52–2.67) 4.62 (3.75) 4.12 (3.80) 0.364 0.13 (−0.58–1.59)
Rule-breaking behaviour 1.58 (1.83) 1.27 (1.61) 0.248 0.17 (−0.21–0.82) 1.86 (2.28) 1.78 (1.92) 0.793 0.03 (−0.53–0.70)
Aggressive behaviour 5.97 (4.37) 3.36 (3.38) <0.001 0.67 (1.45–3.78) 5.90 (5.10) 4.81 (4.88) 0.140 0.21 (−0.36–2.54)
Others 4.29 (3.35) 3.36 (2.60) 0.040 0.31 (0.04–1.83) 4.30 (2.79) 3.94 83.15) 0.397 0.12 (−0.48–1.21)
Internalising 8.68 (8.31) 4.78 (5.05) <0.001 0.58 (1.87–5.92) 9.39 (8.06) 6.16 (6.15) 0.003 0.43 (1.09–5.36)
Externalising 7.55 (5.66) 4.63 (4.62) <0.001 0.62 (5.96–17.25) 7.76 (6.91) 6.58 (6.53) 0.239 0.17 (−0.78–3.13)

Odds ratios

According to the results, children with allergies are 2.76 times more likely to have behaviour problems than children without allergies (P ≤ 0.001; 95% CI [1.61 to 4.72]). The OR of the externalising and the internalising subscales showed similar, significant results (P = 0.03 and 0.001, respectively) indicating the same relationship. The OR was bigger in the internalising factors than in the externalising factors (2.45 against 1.77). The “social problems” factor obtained the highest OR of the overall scale (OR = 3.31; 95% CI [1.52 to 7.19]) followed by the factors: “anxious/depressed” (OR = 2.83; 95% CI [1.41 to 5.66]), “withdrawn/depressed,” “attention problems” and “rule breaking behaviour” factors showed smallest and non-statistically significant OR (95% CI included value of 1).

Allergy severity

Comparisons between those children with mild or moderate level of asthma showed higher and significant scores in the subsample of moderate asthma (Table 4) in the total score and in the internalising subdomain.

Table 4 Comparisons of CBCL scores by level of asthma (mild or moderate).

Mild asthma (n = 151) Moderate asthma (n = 43) P value Mean Difference SMD (95% CI)
CBCL Total, mean (SD) 29.3 (21.4) 38.3 (24.8) 0.019 −9.08 0.4 (1.51–16.64)
Internalising 8.49 (7.68) 11.3 (9.41) 0.049 −2.77 0.34 (0.01–5.52)
Externalising 7.26 (6.05) 9.12 (7.47) 0.09 −1.85 0.29 (0.32–4.03)

CBCL: Child Behaviour Check List; CI: Confidence Interval; SD: Standard Deviation; SMD: Standardised Mean Difference.

Correlations between the number of allergies and CBCL scores did not show relevant results (P < 0.05).


The prevalence of allergies in infants has grown in the last decades.36 Allergies are very often associated with physical, mental and emotional problems that can be detected through children’s behaviours and feelings.22

The results of this study confirm the main hypothesis in children with allergic diseases showing a higher risk of suffering from behavioural problems (internalising and externalising) than healthy subjects. Both types of factors show differences, with those in internalising factors appearing to be greater. These results are similar in other studies.19,37

The secondary hypothesis also appears to be confirmed. Children with allergies showed higher scores in all the subscales with the exception of “rule-breaking behaviour.”

The fact that the subscale of “rule-breaking behaviour” did not show significant differences and the absence of differences in the emotional climate in the family (stress, affective expression, resilience or authority) could be related, in agreement with similar studies that indicated a relationship between oppositional-defiant behaviours and parental discipline styles, socio-environmental factors and personality.38,39 However, this point needs further research.

Analysing each subscale, “somatic complaints” stand out for having the largest mean differences. Obviously, this is directly related to the symptoms derived from the allergies (asthmatic, rhinitis and AD). The rest of the subscales can be connected following other similar studies.21,40 Those children with social problems, thought problems or attention problems experience difficulties in expressing their feelings and emotions which can produce anxious/depressed symptoms or aggressive behaviours. These two subscales have shown the biggest differences in each factor (internalising and externalising, respectively). Secondary analyses comparing scores by group and age have revealed very interesting results that need be explored further in detail. It seems that these differences tend to decrease as the children get older. Maybe this can be related to own maturation process of the child, the acquisition of new behavioural skills or to the less dependency of the parents.

Third hypothesis related with dose-relation analyses showed mixed results. While there was a relation between asthma degree (mild or moderate) and general and internalising behavioural problems, these relations disappear when compared with number of allergies. This situation may be due to the dispersion of the data and a larger sample size may be required.

Despite the efforts to control methodological aspects, these results must be considered within the context of some limitations. Firstly, the study’s principal limitation is related to its cross-sectional design. It would be desirable to carry out a longitudinal study to increase the internal validity of the results. Secondly, despite efforts to recruit subjects in different groups, we failed in the control group, where the number of participants was less than expected in sample size calculations. This limitation could be associated with the lack of parental involvement in a study whose results do not concern them. Thirdly, we have used a simple and ad hoc questionnaire to assess some variables (the aspects related with the allergy and the emotional climate in the family). It would be desirable to use a more precise and well-validated tool to asses these aspects and to make comparisons with other similar and possible studies. In this context, findings should be interpreted with caution and it is not possible to ensure that these differences imply a causal phenomenon.

Last, in this study, odds ratio results indicated that all factors including overall CBCL score and each individual factor showed a higher risk of clinical behavioural problems in the sample of allergic children. In some cases, the risk of showing difficulties or problems is more than three times in the case group than in the control group (social problems). These findings suggest the need to investigate new strategies and interventions to treat and prevent possible mental health diseases in childhood, which is such an important stage in a person’s development.41


These findings suggest an important association between suffering from allergies and the presence of behavioural problems in children from 6 to 11 years. This relationship is stronger in internalising behaviours. Age of the children and moderate asthma appear to be protective variables. Because of the importance of children’s proper mental and physical development and their transition to adulthood, clinicians should pay more attention to possible symptoms related to mental health or behavioural problems, especially in children with multiple allergic diseases or comorbidities. Early treatment and prevention programmes with children and their families that could avoid or reduce the probability of manifesting these difficulties in successive stages may be warranted.


We are grateful to Jennifer Benítez Navas from the Intelecto Psychological Centre, Jerez de la Frontera (Spain).

Ethical disclosures

Protection of human subjects and animals in research

This study has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki).

Right to privacy and informed consent

All participants signed an informed consent. The author for correspondence is in possession of this document.

Funding source

This research did not receive any specific grants from funding agencies in the public, commercial or not-for-profit sectors.

Declaration of interest

The authors have no conflicts of interest to disclose.


1. Pawankar R, Canonica GW, Holgate ST, Lockey RF. White book on allergy 2011–2012 executive summary. World Allergy Organization, Milwaukee, Wisconsin; 2011.

2. Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J, et al. The prevalence, severity, and distribution of childhood food allergy in the United States: The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-up pediatric allergy and immunology in China. Pediatrics. 2011;128:e9–17. 10.1542/peds.2011-0204

3. Peters RL, Koplin JJ, Gurrin LC, Dharmage SC, Wake M, Ponsonby AL, et al. The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-up. J Allergy Clin Immunol. 2017;140:145–53.e8. 10.1016/j.jaci.2017.02.019

4. Wong GWK, Li J, Bao YX, Wang JY, Leung TF, Li LL, et al. Pediatric allergy and immunology in China. Pediatr Allergy Immunol. 2018;29:127–32. 10.1111/pai.12819

5. O’Connell EJ. The burden of atopy and asthma in children. Allergy. 2004;59(Suppl 78):7–11. 10.1111/j.1398-9995.2004.00563.x

6. Loftus PA, Wise SK. Epidemiology and economic burden of asthma. Int Forum Allergy Rhinol. 2015;5(Suppl 1):S7–10. 10.1002/alr.21547

7. Patel N, Herbert L, Green TD. The emotional, social, and financial burden of food allergies on children and their families. Allergy Asthma Proc. 2017;38:88–91. 10.2500/aap.2017.38.4028

8. Fong AT, Katelaris CH, Wainstein B. Bullying and quality of life in children and adolescents with food allergy. J Paediatr Child Health. 2017;53:630–5. 10.1111/jpc.13570

9. Tzeng NS, Chang HA, Chung CH, Kao YC, Chang CC, Yeh HW, et al. Increased risk of psychiatric disorders in allergic diseases: A nationwide, population-based, cohort study. Front Psychiatry. 2018;9:133. 10.3389/fpsyt.2018.00133

10. Rhee CS, Wee JH, Ahn JC, Lee WH, Tan KL, Ahn S, et al. Prevalence, risk factors and comorbidities of allergic rhinitis in South Korea: The Fifth Korea National Health and Nutrition Examination Survey. Am J Rhinol Allergy. 2014;28:e107–14. 10.2500/ajra.2014.28.4040

11. Peters TE, Fritz GK. Psychological considerations of the child with asthma. Child Adolesc Psychiatr Clin N Am. 2010;19:319–33, ix. 10.1016/j.chc.2010.01.006

12. Slim M, Rico-Villademoros F, Calandre EP. Psychiatric comorbidity in children and adults with gluten-related disorders: A narrative review. Nutrients. 2018;10(7):875. 10.3390/nu10070875

13. Withers AL, Green R. Transition for adolescents and young adults with asthma. Front Pediatr. 2019;7:301. 10.3389/fped.2019.00301

14. Miyazaki C, Koyama M, Ota E, Swa T, Mlunde LB, Amiya RM, et al. Allergic diseases in children with attention deficit hyperactivity disorder: A systematic review and meta-analysis. BMC Psychiatry. 2017;17:120. 10.1186/s12888-017-1281-7

15. McGovern CM, Arcoleo K, Melnyk B. COPE for asthma: Outcomes of a cognitive behavioral intervention for children with asthma and anxiety. Sch Psychol. 2019;34:665–76. 10.1037/spq0000310

16. Goodwin RD, Robinson M, Sly PD, McKeague IW, Susser ES, Zubrick SR, et al. Severity and persistence of asthma and mental health: A birth cohort study. Psychol Med. 2013;43:1313–22. 10.1017/S0033291712001754

17. Tajdini M, Effatpanah M, Zaki-Dizaji M, Movahedi M, Parvaneh N, Shariat M, et al. Associations of behavioral disorders with asthma in Iranian children. Iran J Allergy Asthma Immunol. 2019;18:340–5. 10.18502/ijaai.v18i3.1127

18. Teyhan A, Galobardes B, Henderson J. Child allergic symptoms and well-being at school: Findings from ALSPAC, a UK cohort study. PLoS One. 2015;10:e0135271. 10.1371/journal.pone.0135271

19. Nanda MK, LeMasters GK, Levin L, Rothenberg ME, Assa’ad AH, Newman N, et al. Allergic diseases and internalizing behaviors in early childhood. Pediatrics. 2016;137. 10.1542/peds.2015-1922

20. Chang HY, Seo JH, Kim HY, Kwon JW, Kim BJ, Kim HB, et al. Allergic diseases in preschoolers are associated with psychological and behavioural problems. Allergy Asthma Immunol Res. 2013;5:315–21. 10.4168/aair.2013.5.5.315

21. Urrutia-Pereira M, Sole D, Chong Neto HJ, Acosta V, Cepeda AM, Alvarez-Castello M, et al. Sleep disorders in Latin-American children with asthma and/or allergic rhinitis and normal controls. Allergol Immunopathol (Madr). 2017;45:145–51. 10.1016/j.aller.2016.05.005

22. Topal E, Catal F, Soylu N, Ozcan OO, Celiksoy MH, Babayigit A, et al. Psychiatric disorders and symptoms severity in pre-school children with cow’s milk allergy. Allergol Immunopathol (Madr). 2016;44:445–9. 10.1016/j.aller.2016.03.001

23. Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, et al. Major comorbidities of atopic dermatitis: Beyond allergic disorders. Am J Clin Dermatol. 2018;19:821–38. 10.1007/s40257-018-0383-4

24. Xie QW, Dai X, Tang X, Chan CHY, Chan CLW. Risk of mental disorders in children and adolescents with atopic dermatitis: A systematic review and meta-analysis. Front Psychol. 2019;10:1773. 10.3389/fpsyg.2019.01773

25. Lebovidge JS, Strauch H, Kalish LA, Schneider LC. Assessment of psychological distress among children and adolescents with food allergy. J Allergy Clin Immunol. 2009;124:1282–8. 10.1016/j.jaci.2009.08.045

26. Brew BK, Lundholm C, Gong T, Larsson H, Almqvist C. The familial aggregation of atopic diseases and depression or anxiety in children. Clin Exp Allergy. 2018;48:703–11. 10.1111/cea.13127

27. Licari A, Ciprandi R, Marseglia G, Ciprandi G. Anxiety and depression in adolescents with severe asthma and in their parents: Preliminary results after 1 year of treatment. Behav Sci (Basel). 2019;13;9(7):78. 10.3390/bs9070078

28. Sicouri G, Sharpe L, Hudson JL, Dudeney J, Jaffe A, Selvadurai H, et al. Parent-child interactions in children with asthma and anxiety. Behav Res Ther. 2017;97:242–51. 10.1016/j.brat.2017.08.010

29. Tully C, Rose M, Breen S, Herrera N, Shelef DQ, Streisand R, et al. Relationship between parent mood and resilience and child health outcomes in pediatric asthma. Fam Syst Health. 2019;37:167–72. 10.1037/fsh0000417

30. Meštrović-Štefekov J, Novak-Bilić G, Kuna M, Pap N, Lugović-Mihić L. Psychological stress in patients with atopic dermatitis. Acta Dermatovenerol Croat. 2018;26:297–303.

31. Yang CJ, Liu D, Xu ZS, Shi SX, Du YJ. The pro-inflammatory cytokines, salivary cortisol and alpha-amylase are associated with generalized anxiety disorder (GAD) in patients with asthma. Neurosci Lett. 2017;656:15–21. 10.1016/j.neulet.2017.07.021

32. Achenbach TM, Edelbrock CS. Manual for the child behavior checklist and revised child behavior profile. T.M. Achenbach, Vermont (USA); 1983.

33. Sardinero García E, Pedreira Massa JL, Muñiz J. El cuestionario CBCL de Achenbach: Adaptación española y aplicaciones clínico-epidemiológicas. Clín Salud. 1997;8:447–80.

34. Ogundele MO. Behavioural and emotional disorders in childhood: A brief overview for paediatricians. World J Clin Pediatr. 2018;7:9–26. 10.5409/wjcp.v7.i1.9

35. Cohen J. Statistical power analysis for the behavioral sciences. Academic Press, USA; 2013.

36. Pawankar R, Canonica GW, Holgate S, Lockey R. WAO white book on allergy: Update 2013. World Allergy Organization, Milwaukee, Wisconsin; 2013.

37. Infante M, Slattery MJ, Klein MH, Essex MJ. Association of internalizing disorders and allergies in a child and adolescent psychiatry clinical sample. J Clin Psychiatry. 2007;68:1419–25. 10.4088/JCP.v68n0915

38. Becht AI, Prinzie P, Deković M, van den Akker AL, Shiner RL, Rothenberg WA, et al. Child personality facets and overreactive parenting as predictors of aggression and rule-breaking trajectories from childhood to adolescence cross-cultural effects of parent warmth and control on aggression and rule-breaking from ages 8 to 13. Dev Psychopathol. 2016;28:399–413. 10.1017/S0954579415000577

39. Forster M, Grigsby T, Soto DW, Schwartz SJ, Unger JB. The role of bicultural stress and perceived context of reception in the expression of aggression and rule breaking behaviors among recent-immigrant Hispanic youth. J Interpers Violence. 2015;30:1807–27. 10.1177/0886260514549052

40. Garg N, Silverberg JI. Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. Ann Allergy Asthma Immunol. 2014;112:525–32. 10.1016/j.anai.2014.03.006

41. El Hennawi Del D, Ahmed MR, Farid AM. Psychological stress and its relationship with persistent allergic rhinitis. Eur Arch Otorhinolaryngol. 2016;273:899–904. 10.1007/s00405-015-3641-6